Medy-Tox Inc. (KOSDAQ:086900)

Medy-Tox Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	853,557	831,097	1,621,720	806,183	876,202	1,017,738
Market Cap Growth	-34.09%	-48.75%	101.16%	-7.99%	-13.91%	-39.32%
Enterprise Value	887,480	890,261	1,671,460	885,688	929,154	1,099,207
Last Close Price	121600.00	123558.21	237269.69	125467.58	133151.58	153249.01
PE Ratio	42.92	52.01	184.70	22.37	9.40	-
Forward PE	22.31	19.78	31.76	27.88	23.25	107.65
PS Ratio	3.64	3.64	7.33	4.13	4.74	7.23
PB Ratio	1.84	1.74	3.42	1.86	2.17	4.16
P/TBV Ratio	1.90	1.84	3.49	1.90	2.23	4.48
P/FCF Ratio	18.46	29.86	276.65	49.45	357.35	-
P/OCF Ratio	15.69	22.74	119.94	30.77	43.89	36.44
PEG Ratio	-	1.57	1.57	1.57	1.57	1.57
EV/Sales Ratio	3.78	3.89	7.56	4.54	5.03	7.81
EV/EBITDA Ratio	19.46	22.09	51.12	14.34	18.08	-
EV/EBIT Ratio	34.80	43.75	96.49	18.98	28.04	-
EV/FCF Ratio	19.19	31.99	285.14	54.32	378.95	-
Debt / Equity Ratio	0.17	0.17	0.18	0.28	0.33	0.60
Debt / EBITDA Ratio	1.97	2.02	2.53	1.96	2.59	-
Debt / FCF Ratio	1.66	2.92	14.13	7.41	54.21	-
Asset Turnover	0.39	0.37	0.37	0.33	0.35	0.32
Inventory Turnover	1.79	1.45	1.56	1.61	2.25	2.00
Quick Ratio	1.16	1.04	0.79	0.57	1.14	0.81
Current Ratio	1.80	1.67	1.31	1.00	1.49	1.18
Return on Equity (ROE)	3.76%	3.38%	2.13%	8.74%	28.77%	-11.84%
Return on Assets (ROA)	1.96%	2.07%	1.79%	4.97%	3.96%	-5.21%
Return on Capital (ROIC)	2.11%	2.28%	1.95%	5.35%	4.46%	-6.12%
Return on Capital Employed (ROCE)	3.80%	4.00%	3.60%	10.10%	7.10%	-
Earnings Yield	2.13%	2.04%	0.60%	4.59%	10.75%	-2.91%
FCF Yield	5.42%	3.35%	0.36%	2.02%	0.28%	-1.30%
Dividend Yield	0.90%	0.89%	-	-	-	-
Payout Ratio	43.89%	49.69%	86.33%	21.74%	-	-
Buyback Yield / Dilution	2.69%	-0.40%	-2.02%	-2.28%	-0.04%	0.82%
Total Shareholder Return	3.59%	0.49%	-2.02%	-2.28%	-0.04%	0.82%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.